文献速递关节外科创伤骨科

抗生素骨水泥间隔物治疗假体周围关节感染时抗生素的系统性吸收

Systemic Absorption of Antibiotics From Antibiotic-Loaded Cement Spacers for the Treatment of Periprosthetic Joint Infection.
PubMed 文献 · J Arthroplasty · 2017-10-05

这项前瞻性研究纳入21例感染性初次全髋或全膝关节置换术后患者,使用含万古霉素、庆大霉素和妥布霉素的标准化抗生素骨水泥间隔物,每周检测血清抗生素水平共8周。结果显示抗生素系统性吸收持续至少8周,糖尿病、血尿素氮、骨水泥剂量和全身万古霉素使用与血清万古霉素水平相关,年龄和男性与血清氨基糖苷类水平相关。作者建议密切监测与抗生素系统性吸收相关的并发症。

要点

  • 含万古霉素、庆大霉素和妥布霉素的高剂量抗生素骨水泥间隔物置入后,血清抗生素水平在8周治疗期间持续可检测。
  • 糖尿病、血尿素氮、骨水泥剂量和全身万古霉素使用与血清万古霉素水平相关。
  • 年龄和男性与血清氨基糖苷类水平相关,作者建议密切监测系统性吸收相关并发症。

核心结论

  • 高剂量抗生素骨水泥间隔物的抗生素系统性吸收持续至少8周,患者应密切监测与抗生素系统性吸收相关的并发症。

研究设计与样本

  • 前瞻性研究,纳入21例感染性初次全髋关节置换术(THA,10例)或全膝关节置换术(TKA,11例)患者,使用含万古霉素、庆大霉素和妥布霉素的标准化抗生素骨水泥间隔物,每周采集血清抗生素水平共8周。

主要发现

  • 平均血清庆大霉素水平范围为0.275±0.046至0.364±0.163 mg/L。
  • 平均血清妥布霉素水平范围为0.313±0.207至0.527±0.424 mg/L。
  • 平均血清万古霉素水平范围为5.46±6.6至15.34±9.6 mg/L。
  • 血清抗生素水平在8周抗生素骨水泥间隔物治疗期间持续可检测。
  • 回归分析显示糖尿病(系数6.73,95%CI 0.92-12.54,P<.05)、血尿素氮(系数0.83,95%CI 0.45-1.22,P<.001)、骨水泥剂量数(系数3.71,95%CI 0.76-6.66,P<.05)和全身万古霉素使用(系数6.24,95%CI 2.72-9.75,P<.001)与血清万古霉素水平相关;年龄(系数-0.01,95%CI -0.02至0,P<.01)和男性(系数0.20,95%CI 0-0.41,P<.05)与血清氨基糖苷类水平相关。

临床怎么用

  • 作者建议密切监测接受高剂量抗生素骨水泥间隔物治疗的患者,以发现与抗生素系统性吸收相关的并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two-stage treatment of periprosthetic joint infections involves placement of high-dose antibiotic-loaded cement spacers (ACSs). Reports of ACS-induced nephrotoxicity have raised concern regarding systemic absorption of antibiotics after ACS placement. We sought to characterize the serum concentrations of antibiotics that occur after ACS placement. METHODS: We performed a prospective study of patients with an infected primary total hip (THA) or knee arthroplasty (TKA) treated with standardized ACSs with vancomycin, gentamicin, and tobramycin. Serum antibiotic levels were collected weekly for 8 weeks. RESULTS: Twenty-one patients (10 THA, 11 TKA) were included. Mean serum gentamicin levels ranged between 0.275±0.046 and 0.364±0.163 mg/L; mean serum tobramycin levels ranged from 0.313±0.207 to 0.527±0.424 mg/L; and mean serum vancomycin levels ranged from 5.46±6.6 to 15.34±9.6 mg/L. Serum antibiotic levels were detectable throughout the 8-week duration of ACS treatment. Regression analysis found that diabetes (coefficient 6.73, 95% CI 0.92-12.54, P < .05), blood urea nitrogen (coefficient 0.83, 95% CI 0.45-1.22, P < .001), number of cement doses (coefficient 3.71, 95% CI 0.76-6.66, P < .05), and use of systemic vancomycin (coefficient 6.24, 95% CI 2.72-9.75, P < .001) correlated with serum vancomycin levels. Patient age (coefficient -0.01, 95% CI -0.02 to 0, P < .01) and male sex (coefficient 0.20, 95% CI 0-0.41, P < .05) correlated with serum aminoglycoside level. CONCLUSION: Systemic absorption of antibiotics from high-dose ACS persists for at least 8 weeks. Patients should be monitored closely for complications related to systemic absorption of antibiotics from ACS treatment.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Edelstein AI, Okroj KT, Rogers T, et al. Systemic Absorption of Antibiotics From Antibiotic-Loaded Cement Spacers for the Treatment of Periprosthetic Joint Infection. J Arthroplasty. 2017. PMID: 29103776. doi:10.1016/j.arth.2017.09.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。